Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-25 @ 3:00 PM
Study NCT ID:
NCT06023368
Status:
WITHDRAWN
Last Update Posted:
2024-11-14
First Post:
2023-08-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray
Sponsor:
Marianne Hutti
Organization:
Study Overview
Official Title:
Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray
Status:
WITHDRAWN
Status Verified Date:
2024-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Administrative burden
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to compare a sterile vapocoolant spray to EMLA cream in children with access ports.
Participants will receive either the spray or cream prior to port access and rate pain on a scale.
Researchers will compare spray vs cream to see if the spray is as effective as the cream in reducing pain associated with port puncture.
Participants will receive either the spray or cream prior to port access and rate pain on a scale.
Researchers will compare spray vs cream to see if the spray is as effective as the cream in reducing pain associated with port puncture.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: